Serum Aspartic Acid as a Marker of Epilepsy
Gheyath AlGawwam,
Asaad Adil Mnaather,
Akram Al-Mahdawi,
Hayder A. Fawzi and
Laith G. Shareef
Global Journal of Health Science, 2019, vol. 11, issue 2, 142
Abstract:
OBJECTIVE- Determine the diagnostic validity of serum aspartic acid as a predictor of epilepsy. STUDY DESIGN & METHODOLOGY- This study enrolled 80 epileptic patients and 80 healthy people, and we measure serum level of aspartic acid by using high liquid performance chromatography. RESULTS- Mean serum aspartic acid was significantly higher in patients (26.2 ± 10.1) mg\dl while in control was (2.8 ± 1.36) mg\dl, the result showed that aspartic acid is an excellent predictor area under the curve [AUC] (95%CI) = 0.988 (0.97 – 1.0) with 96.3% sensitivity and 97.5% specificity for epileptic patients. Also, the result shows generalized seizure has significantly higher mean serum aspartic acid compared to partial type and GTC show significantly higher mean serum aspartic acid compared to myoclonus. CONCLUSION- Aspartic acid serum level markedly elevated in epileptic patients groups in comparison to the healthy group, also shows a marked difference between generalized and partial epilepsy and show different levels between subtypes of epilepsy.
Date: 2019
References: View complete reference list from CitEc
Citations:
Downloads: (external link)
http://www.ccsenet.org/journal/index.php/gjhs/article/download/0/0/38277/42836 (application/pdf)
http://www.ccsenet.org/journal/index.php/gjhs/article/view/0/38277 (text/html)
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:ibn:gjhsjl:v:11:y:2019:i:2:p:142
Access Statistics for this article
More articles in Global Journal of Health Science from Canadian Center of Science and Education Contact information at EDIRC.
Bibliographic data for series maintained by Canadian Center of Science and Education ().